Target intelligence / Profile preview

Nucleotidyl-transferase domain (NTase)

Target
NTase
Molecular classification
Enzyme (transferase superfamily), Polymerase (e.g., DNA/RNA polymerases), Ligase (in context of some functions), Cyclase (e.g., adenylyl cyclase), Synthase (e.g., poly(A) polymerase, 2′–5′-oligoadenylate synthetase)
01

Overview

The nucleotidyl-transferase domain is a conserved catalytic domain present in a large enzyme superfamily involved in nucleotide group transfers. Enzymes harboring this domain include DNA and RNA polymerases, poly(A) polymerases, and enzymes conferring antibiotic resistance, among others. The domain features a signature α/β fold and conserved carboxylate residues crucial for catalysis and divalent ion coordination. NTase domain-containing proteins are essential in processes such as nucleic acid metabolism, signal transduction, chromatin remodeling, immunological diversity (V(D)J recombination), and stress/defense responses. The NTase fold superfamily encompasses nearly 43 human genes, with roles in health and disease ranging from immunity to neurodevelopment and cancer. Targeting specific enzymes with NTase domains is an important therapeutic strategy in antiviral, antibacterial, and chemotherapeutic contexts[1][2][3][5][6].

Other names
NTase domainNucleotidyltransferase foldDNA polymerase beta-like nucleotidyltransferasePol beta-like domain
02

Mechanism of action

Inhibition of nucleotidyl-transferase catalytic activity (e.g., DNA/RNA polymerase inhibitors, OAS inhibitors) Modulation of nucleotide transfer to disrupt genetic replication, repair, or editing Blockade of antibiotic resistance enzyme function

03

Biological functions

DNA repairRNA maturation and processingDNA replication and recombinationChromatin remodelingProtein activity regulationAntibiotic resistance (modification of aminoglycosides)Intracellular signal transductionRegulation of apoptosis, cell growth, and differentiation
04

Disease associations

CancerNeurologic diseasesCongenital muscular dystrophyRetinal pigmentosaInfection (including antiviral and antibacterial resistance)Type 1 diabetesOther (in context of stress response and immunity)
05

Safety considerations

Off-target effects due to conservation of domain structure across many essential enzymesImpact on DNA/RNA repair and immune functionsPotential development of drug resistance, especially in bacteria
06

Interacting drugs

Antiviral agents (targeting OAS family in interferon pathways)

3 more in the full profile.

07

Biomarkers

Mutations in OAS1/2/3 (interferon response)Genetic variants in DNA polymerases linked to disease statesExpression levels of specific NTase domain-containing proteins (e.g., TdT in leukemia diagnosis)

Beyond the preview

Go deeper on Nucleotidyl-transferase domain (NTase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleotidyl-transferase domain (NTase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call